The efficacy of long-term conjugated linoleic acid (CLA) supplementation on body composition in overweight and obese individuals: a systematic review and meta-analysis of randomized clinical trials (original) (raw)

References

  1. Ogden CL, Yanovski SZ, Carroll MD, Flegal KM (2007) The epidemiology of obesity. Gastroentorology 132:2087–2102
    Article Google Scholar
  2. Belury M (2002) Dietary conjugated linoleic acid in health: physiological effects and mechanisms of action. Ann Rev Nutr 22:505–531
    Article CAS Google Scholar
  3. Chin SF, Liu W, Storkson JM, Ha YL, Pariza MW (1992) Dietary sources of conjugated dienoic isomers of linoleic acid, a newly recognized class of anticarcinogens. J Food Compos Anal 5:185–197
    Article CAS Google Scholar
  4. Whigham LD, Watras AC, Schoeller DA (2007) Efficacy of conjugated linoleic acid for reducing fat mass: a meta-analysis in humans. Am J Clin Nutr 85(5):1203–1211
    CAS Google Scholar
  5. Brown J, McIntosh M (2003) Conjugated linoleic acid in humans: regulation of adiposity and insulin sensitivity. J Nutr 133:3041–3046
    CAS Google Scholar
  6. Mirand PP, Arnal-Bagnard MA, Mosoni L et al (2004) Cis-9, trans-11 and trans-10, cis-12 conjugated linoleic acid isomers do not modify body composition in adult sedentary or exercised rats. J Nutr 134(9):2263–2269
    CAS Google Scholar
  7. Baddini FA, Fernandes PA, Ferreria da Costa N, Gonçalves RB (2009) Conjugated linoleic acid (CLA): effect modulation of body composition and lipid profile. Nutr Hosp 24(4):422–428
    Google Scholar
  8. Salas-Salvadó J, Márquez-Sandoval F, Bulló M (2006) Conjugated linoleic acid intake in humans: a systematic review focussing on its effect on body composition, glucose, and lipid metabolism. Cri Rev Food Sci Nutr 46:479–488
    Article Google Scholar
  9. Moher D, Schulz KF, Altman DG (2001) The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. Lancet 357(9263):1191–1194
    Article CAS Google Scholar
  10. Altman DG, Schulz KF, Moher D, Egger M, Davidoff F, Elbourne D, Gøtzsche PC, Lang T (2001) The revised CONSORT statement for reporting randomised trials: explanation and elaboration. Ann Intern Med 134(8):663–694
    CAS Google Scholar
  11. Review Manager (RevMan) [Computer Program] (2008) Version 5.0. The Nordic Cochrane Centre, The Cochrane Collaboration, Copenhagen
  12. Gaullier J-M, Halse J, Høye K, Kristiansen K, Fagertun H, Vik H et al (2005) Supplementation with conjugated linoleic acid for 24 months is well tolerated by and reduces body fat mass in healthy, overweight humans. J Nutr 135:778–784
    CAS Google Scholar
  13. Venkatramanan S, Joseph SV, Chouinard PY, Jacques H, Farnworth ER, Jones PJH (2010) Milk enriched with conjugated linoleic acid fails to alter blood lipids or body composition in moderately overweight, borderline hyperlipidemic individuals. J Am Coll Nutr 29(2):152–159
    CAS Google Scholar
  14. Von Loeffelholz C, von Loeffelholz B, Jahreis G (1999) Influence of CLA supplementation on body composition and strength in body builders. Vitamins and Additives in Human and Animal Nutrition 238–243
  15. Von Loeffelholz C, Kratzsch J, Jahreis G (2003) Influence of conjugated linoleic acids on body composition and selected serum and endocrine parameters in resistance-trained athletes. Eur J Lipid Sci 105:251–259
    Article Google Scholar
  16. Tarnopolsky M, Zimmer A, Jeremy P, Safdar A, Aboud A, Pearce E, et al (2007) Creatine monohydrate and conjugated linoleic acid improve strength and body composition following resistance exercise in older adults. PLoS ONE 2(10):E991. doi:10.1371/journal.pone.0000991
  17. Moya MJ (2007) Use of conjugated linoleic acid in obese children and adolescents. Revista Espanola de Pediatria 63(3):453–457
    Google Scholar
  18. Close RN, Schoeller DA, Watras AC, Nora EH (2007) Conjugated linoleic acid supplementation alters the 6-mo change in fat oxidation during sleep. Am J Clin Nutr 86:797–804
    CAS Google Scholar
  19. Syvertsen C, Halse J, Høivik HO, Gaullier J-M, Nurminiemi M, Kristiansen K et al (2007) The effect of 6 months supplementation with conjugated linoleic acid on insulin resistance in overweight and obese. Int J Obes 31(7):1148–1154
    Article CAS Google Scholar
  20. Gaullier J-M, Halse J, Høivik HO, Høye K, Syvertsen C, Nurminiemi M et al (2007) Six months supplementation with conjugated linoleic acid induces regional-specific fat mass decreases in overweight and obese. Br J Nutr 97:550–560
    Article CAS Google Scholar
  21. Gaullier J-M, Halse J, Høye K, Kristiansen K, Fagertun H, Vik H et al (2004) Conjugated linoleic acid supplementation for 1 year reduces body fat mass in healthy overweight humans. Am J Clin Nutr 79(6):1118–1125
    CAS Google Scholar
  22. Larsen TM, Toubro S, Gudmundsen O, Astrup A (2006) Conjugated linoleic acid supplementation for 1 year does not prevent weight or body fat regain. Am J Clin Nutr 83(3):606–612
    CAS Google Scholar
  23. Racine NM, Watras AC, Carrel AL, Allen DB, McVean JJ, Clark RR, et al (2010) Effect of conjugated linoleic acid on body fat accretion in overweight or obese children. Am J Clin Nutr. doi:10.3945/ajcn.2009.28404
  24. Sluijs I, Plantinga Y, de Roos B, Mennen LI, Bots ML (2010) Dietary supplementation with cis-9, trans-11 conjugated linoleic acid and aortic stiffness in overweight and obese adults. Am J Clin Nutr 91(1):175–183
    Article CAS Google Scholar
  25. Watras AC, Buchholz AC, Close RN, Zhang Z, Schoeller DA (2007) The role of conjugated linoleic acid in reducing body fat and preventing holiday weight gain. Int J Obes 31(3):481–487
    Article CAS Google Scholar
  26. Whigham LD, O’Shea M, Mohede ICM, Walaski HP, Atkinson RL (2004) Safety profile of conjugated linoleic acid in a 12-month trial in obese humans. Food Chem Toxicol 42:1701–1709
    Article CAS Google Scholar
  27. Christian JG, Tsai AG, Bessesen DH (2010) Interpreting weight loss from lifestyle modification trials: using categorical data. Int J Obes 34(1):207–209
    Article CAS Google Scholar
  28. Lachim JM (2000) Statistical Considerations in the Intent-to-Treat Principle. Control Clin Trials 21(3):167–169
    Article Google Scholar
  29. Hollis S, Campbell F (1999) What is meant by intention to treat analysis? Survey of published randomised controlled trials. BMJ 319(7211):670–674
    Article CAS Google Scholar
  30. (1998) Safflower oil consumption does not increase plasma conjugated linoleic acid concentrations in humans. Am J Clin Nutr 67(2):332–337
  31. Raff M, Tholstrup T, Basu S, Nonboe P, Sørensen MT, Straarup EM (2008) A diet rich in conjugated linoleic acid and butter increases lipid peroxidation but does not affect atherosclerotic, inflammatory or diabetic risk markers in healthy young men. J Nutr 138(3):509–514
    CAS Google Scholar
  32. Avenell A, Sattar N, Lean M (2007) Management: part I-behaviour change, diet, and activity. In: Sattar N, Lean M (eds) ABC of obesity. Blackwell, Malden, pp 8–11
    Google Scholar
  33. Yusuf S, Hawken S, Ounpuu S, Bautista L, Franzosi MG, Commerford P (2005) Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case–control study. Lancet 366(9497):1640–1649
    Article Google Scholar

Download references